Skip to main content
See every side of every news story
Published loading...Updated

Modified Lipid Nanoparticles Boost mRNA Vaccine Delivery to Lymph Nodes

Lipid nanoparticles have become the workhorse of mRNA vaccines, ferrying genetic cargo into cells so the immune system can learn to recognize a threat. But most LNPs don’t travel where vaccine developers would ideally want them to go. Instead of homing to immune tissues, they tend to accumulate in the liver—a biological detour that can limit efficacy and contribute to side effects. A team at the University of Pennsylvania School of Engineering a…

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

GEN - Genetic Engineering and Biotechnology News… broke the news in on Tuesday, March 24, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal